Evidence map›Paper›PMID 21922669›Full record

ArticleBiotechnology journal2012

Enhanced growth and hepatic differentiation of fetal liver epithelial cells through combinational and temporal adjustment of soluble factors.

Lichuan Qian, Diane S Krause, W Mark Saltzman

Open access · greenAbstract read
In one paragraph

Article in Biotechnology journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Extramedullary Hematopoiesis of the Liver and Spleen.Journal of clinical medicine · 2021
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lichuan QianDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.
Diane S Krause
W Mark Saltzman
Yale University · US

Funding

Optimizing Therapeutic Revascularization by Endothelial Cell TransplantationR01HL085416 · NHLBI · YALE UNIVERSITY · PI POBER, JORDAN S, SALTZMAN, W. MARK · 2006 to 2019
$5.9M
Type II pneumocyte engraftment of bone marrow stem cellsR01HL073742 · NHLBI · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2003 to 2012
$3.5M
Epithelial engraftment of bone marrow derived stem cellsR01DK061846 · NIDDK · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2001 to 2008
$2.5M
Micro-and Nano-engineering of Biomineralized MaterialsR01DE014097 · NIDCR · YALE UNIVERSITY · PI SALTZMAN, W MARK · 2002 to 2006
$1.4M
NHLBI NIH HHS HL073742NHLBI NIH HHS HL085416NHLBI NIH HHS R01 HL073742NHLBI NIH HHS R01 HL085416NIDCR NIH HHS DE14097NIDCR NIH HHS R01 DE014097NIDDK NIH HHS DK61846NIDDK NIH HHS R01 DK061846
6 · The paper itself

Abstract

Fetal liver epithelial cells (FLEC) are valuable for liver cell therapy and tissue engineering, but methods for culture and characterization of these cells are not well developed. This work explores the influence of multiple soluble factors on FLEC, with the long-term goal of developing an optimal culture system to generate functional liver tissue. Our comparative analysis suggests hepatocyte growth factor (HGF) is required throughout the culture period. In the presence of HGF, addition of oncostatin M (OSM) at culture initiation results in concurrent growth and maturation, while constant presence of protective agents like ascorbic acid enhances cell survival. Study observations led to the development of a culture medium that provided optimal growth and hepatic differentiation conditions. FLEC expansion was observed to be approximately twofold of that under standard conditions, albumin secretion rate was 2-3 times greater than maximal values obtained with other media, and the highest level of glycogen accumulation among all conditions was observed with the developed medium. Our findings serve to advance culture methods for liver progenitors in cell therapy and tissue engineering applications.

Indexed as

AlbuminsAnimalsAscorbic AcidCell Culture TechniquesCell DifferentiationCell SurvivalCulture MediaEpithelial CellsGlycogenHepatocyte Growth FactorLiverMiceMice, Inbred C57BLOncostatin MTissue EngineeringAlbuminsAscorbic AcidCulture MediaGlycogenHepatocyte Growth FactorOncostatin M

Identifiers

PMID21922669
PMCPMC3532892
OpenAlexW2119804055

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.